Abstract
Desmosterolosis is a rare, autosomal recessive, human disease characterized by multiple congenital anomalies in conjunction with grossly elevated levels of desmosterol and markedly reduced levels of cholesterol in all bodily tissues. Herein, we evaluated retinal sterol composition, histology, and electrophysiological function in an animal model that exhibited the biochemical features of desmosterolosis, produced by treating pregnant rats and their progeny with U18666A, an inhibitor of desmosterol reductase. Treated rats had cataracts, were substantially smaller, and had markedly high levels of desmosterol and profoundly low levels of cholesterol in their retinas and other tissues compared to age-matched controls. However, their retinas were histologically normal and electrophysiologically functional. These results suggest that desmosterol may be able to replace cholesterol in the retina, both structurally and functionally. These findings are discussed in the context of “sterol synergism.”
Similar content being viewed by others
REFERENCES
Fliesler, S. J., and Keller, R. K. 1997. Isoprenoid metabolism in the vertebrate retina. Int. J. Biochem. Cell Biol. 29:877-894.
Cenedella, R. J. 1996. Cholesterol and cataracts. Survey Ophthalmol. 40:320-337.
Roux, C. 1964. Action teratogéne du triparanol chéz l'animal. Arch. Franc Pediatr. 21:451-464.
Roux, C., and Aubry, M. 1966. Action teratogéne chez le rat d'un inhibiteur de la synthese due cholesterol, AY9944. Compt. Rend. Seances Soc. Biol. Filiales., 160:1353-1357.
Barbu, V., Roux, C., Dupuis, R., Gardette, J., and Maziere, J. C. 1984. Teratogenic effect of AY9944 in rats: importance of the day of administration and maternal plasma cholesterol level. Proc. Soc. Exp. Biol. Med. 176:54-59.
Roux, C., Horvath, C., and Dupuis, R. 1979. Teratogenic action and embryo lethality of AY9944: Prevention by a hypercholesterolemia-provoking diet. Teratology, 19:35-38.
Smith, D. W., Lemmli, L., and Opitz, J. M. 1964. A newly recognized syndrome of multiple congenital anomalies. J. Pediatr. 64:210-217.
Tint, G. S., Batta, A. K., Xu, G., Shefer, S., Honda, A., Irons, M., Elias E. R., and Salen, G. 1997. The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis. Pages 117-144, in Bittman, R. (Ed.), Subcellular Biochemistry, Vol. 28, Plenum Press, New York.
Kelley, R. I. 1998. RSH/Smith-Lemli-Opitz syndrome: mutations and metabolic morphogenesis. Am. J. Hum. Genet. 63: 322-326.
Clayton, P., Mills, K., Keeling, J., and FitzPatrick, D. R. 1996. Desmosterolosis: a new inborn error of cholesterol metabolism. Lancet, 348:404.
FitzPatrick, D. R., Keeling, J. W., Evans, M. J., Kan, A. E., Bell, J. E., Porteous, M. E. M., Mills, K., Winter, R. M., and Clayton, P. T. 1998. Clinical phenotype of Desmosterolosis. Am. J. Med. Genet. 75:145-152.
Avigan, J., Steinberg, D., Vroman, H. E., Thompson, M. J., and Mossettig, E. 1960. Studies of cholesterol biosynthesis. I. The identification of desmosterol in serum and tissues of animals and men treated with Mer-29. J. Biol. Chem. 235:3123-3126.
Steinberg, D., and Avigan, J. 1960. Studies on cholesterol biosynthesis. II. The role of desmosterol in the biosynthesis of cholesterol. J. Biol. Chem. 235:3127-3129.
Fumagalli, R., Grossi-Paoletti, E., Paoletti, P., and Paoletti, R. 1966. Lipids in brain tumours. II. Effect of triparanol and 20,25-diazacholesterol on sterol composition in experimental and human brain tumours. J. Neurochem. 13:1005-1010.
Suzuki, K., Zagoren, J. C., Chen, S. M., and Suzuki,K. 1974. Effects of triparanol and 20,25-diazacholesterol in CNS of rat: morphological and biochemical studies. Acta Neuropathol. (Berl.) 29:141-156.
Phillips, W. A., and Avigan, J. 1963. Inhibition of cholesterol biosynthesis in the rat by 3β-(2-diethylamino-ethoxy)androst-5-en-17-one, hydrochloride. Prod. Soc. Exp. Bio. Med. 112: 233-236.
Cenedella, R. J. 1980. Concentration-dependent effects of AY-9944 and U18666A on sterol synthesis in brain. Biochem. Pharmacol. 29:2751-2754.
Sexton, R. C., Panini, S. R., Azran, F., and Rudney, H. 1983. Effects of 3β-[2-(diethylamino) ethoxy]androst-5-en-17-one on the synthesis of cholesterol and ubiquinone in rat intestinal epithelial cell cultures. Biochemistry, 22:5687-5692.
Duriatti, A., Bouvier-Nave, P., Benveniste, P., Schuber, F., Delprino, L., Balliano, G., and Cattel, L. 1985. In vitro inhibition of animal and higher plants 2,3-oxidosqualene-sterol cyclases by 2-aza-2,3-dihydrosqualene and derivatives, and by other ammonium-containing molecules. Biochem. Pharmacol. 34: 2765-2777.
Cenedella, R. J., and Bierkamper, G. G. 1979. Mechanism of cataract production by 3-β(2-diethylaminoethoxy)androst-5-en-17-one hydrochloride, U18666A: An inhibitor of cholesterol biosynthesis. Exp. Eye Res. 28:673-688.
Cenedella, R. J. 1982. Source of cholesterol for the ocular lens, studied with U18666A: A cataract-producing inhibitor of lipid metabolism. Exp. Eye Res. 37:33-43.
Bierkamper, G. G., and Cenedella, R. J. 1978. Induction of chronic epileptiform activity in the rat by an inhibitor of cholesterol biosynthesis, U18666A. Brain Res. 150:343-351.
von Sallmann, L. 1963. Triparanol-induced cataracts in rats. Trans. Amer. Ophthalmol. Soc. 61:49-60.
Kirby, T. J. 1967. Cataracts produced by triparanol. (MER-29). Trans. Am. Ophthalmol. Soc. 65:494-543.
Harris, J. E. and Graber, L. 1969. The reversal of triparanol-induced cataracts in the rat. Doc. Ophthalmol. 26:324-333.
Fliesler, S. J., Richards, M. J., Miller, C.-Y., and Cenedella, R. J. 2000. Cholesterol synthesis in the vertebrate retina: Effects of U18666A on rat retinal structure, photoreceptor membrane assembly, and sterol metabolism and composition. Lipids 35:289-296.
Fliesler, S. J., Florman, R., and Keller, R. K. 1995. Isoprenoid lipid metabolism in the retina: Dynamics of squalene and cholesterol incorporation and turnover in frog rod outer segment membranes. Exp. Eye Res. 60:57-69.
Fliesler, S. J., Richards, M. J., Miller, C.-Y., and Peachey, N. S. 1999. Marked alteration of sterol metabolism and composition without compromising retinal development or function. Invest. Ophthalmol. Vis. Sci. 40:1792-1801.
Carson, F. 1990. Histotechnology-A Self Instruction Text. Chicago, IL: American Society for Clinical Pathologists Press.
Goto, Y., Peachey, N. S., Ziroli, N. E., Seiple, W. H., Gryczan, C., Pepperberg, D. R., and Naash, M. I. 1996. Rod phototransduction in transgenic mice expressing a mutant opsin gene. J. Opt. Soc. Amer. A. 13:577-585.
Fliesler, S. J., and Keller, R. K. 1995. Metabolism of [3H]farnesol to cholesterol and cholesterogenic intermediates in the living rat eye. Biochem. Biophys. Res. Commun. 210:695-702.
Dvornik, D., Kraml, M., Dubuc, J., Givner, M., and Gaudry, R. 1963. A novel mode of inhibition of cholesterol biosynthesis. J. Am. Chem. Soc. 85:3309.
Givner, M. L., and Dvornik, D. 1965. Agents affecting lipid metabolism-XV. Biochemical studies with the cholesterol biosynthesis inhibitor AY-9944 in young and mature rats. Biochem. Pharmacol. 14:611-619.
Irons, M., Elias, E. R., Salen, G., Tint, G. S., and Batta, A. K. 1993. Defective cholesterol metabolism in Smith-Lemli-Opitz syndrome. Lancet, 341:1414.
Tint, G. S., Salen, G., Batta, A. K., Shefer, S., Irons, M., Ampola, M., and Frieden, R. 1993. Abnormal cholesterol and bile acid biosynthesis in an infant with a defect in 7-dehdrocholesterol (7-DHC)-Δ7 reductase. Gastroenterology (Abstract), 104:A1008.
Tint, G. S., Irons, M., Elias, E. R., Batta, A. K., Frieden, R., Chen, T. S., and Salen, G. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Eng. J. Med. 330:107-113.
Chen, J.-F., Elsner, A. E., Burns, S. A., Hansen, R. M., Lou, P. L., Kwong, K. K., and Fulton, A. B. 1992. The effect of eye shape on retinal responses. Clin. Vis. Sci. 6:521-530.
Pallin, O. 1969. Influence of axial length of the eye on the size of the recorded b-potential in the clinical single-flash electroretinogram. Acta Ophthal. (Suppl.) 47:1-57.
Dahl, J. S., Dahl, C. E., and Bloch, K. 1980. Sterols in membranes: Growth characteristics and membrane properties of Mycoplasma capricolum cultured on cholesterol and lanosterol. Biochemistry 19:1467-1472.
Dahl, J. S., Dahl, C. E., and Block, K. 1981. Effect of cholesterol on macromolecular synthesis and fatty acid uptake by Mycoplasma capricolum. J. Biol. Chem. 256:87-91.
Ramgopal, M., and Block, K. 1983. Sterol synergism in yeast. Proc. Natl. Acad. Sci. USA, 80:712-715.
Parks, L. W., and Casey, Wm. 1995. Physiological implications of sterol biosynthesis in yeast. Ann. Rev. Microbiol. 49:95-116.
Whitaker, B. D., and Nelson, D. L. 1988. Sterol synergism in Paramecium tetraurelia. J. Gen. Microbiol. 134:1441-1447.
Rujanavech, C., and Silbert, D. F. 1986. LM cell growth and membrane lipid adaptation to sterol structure. J. Biol. Chem. 261:7196-7203.
Baldassare, J. J., Saito, Y., and Silbert, D. F. 1979. Effect of sterol depletion on LM cell sterol mutants. Changes in the lipid composition of the plasma membrane and their effects on 3-Omethyl glucose transport. J. Biol. Chem. 254:1108-1113.
Yeagle, P. L. 1990. Role of cholesterol in cellular functions. Pages 111-132, in Esfahani, M., and Swaney, J. B. (eds.), Advances in Cholesterol Research, The Telford Press, New Jersey.
Bastiaanse, E. M., Hold, K. M., and Van der Laarse, A. 1997. The effects of membrane cholesterol on ion transport in plasma membranes. Cardiovasc. Res. 33:272-283.
LeGrimellec, C., Friedlander, G., el Yandouzi, E. H., Zlatkine, P., and Giocondi, M. C. 1992. Membrane fluidity and transport properties in epithelia. Kidney Intl. 42:825-836.
Lenaz, G. 1987. Lipid fluidity and membrane protein dynamics. Bio. Sci. Rep. 7:823-837.
Demel, R. A., Bruckdorfer, K. R., and van Deenen, L. L. M. 1972. The effect of sterol structure on the permeability of liposomes to glucose, glycerol, and Rb+. Biochim. Biophys. Acta. 255:321-330.
Vemuri, R., and Philipson, K. D. 1989. Influence of sterols and phospholipids on sarcolemmal and sarcoplasmic reticular cation transporters. J. Biol. Chem. 264:8680-8685.
Nes, W. R., Sekula, B. C., Nes, W. D., and Adler, J. H. 1978. The functional importance of structural features of ergosterol in yeast. J. Biol. Chem. 253:6218-6225.
Fliesler, S. J., and Anderson, R. E. 1983. Chemistry and metabolism of lipids in the vertebrate retina. Progr. Lipid Res. 22: 79-131.
Bloch, K. 1983. Sterol structure and membrane function. Crit. Rev. Biochem. 14:47-92.
Yeagle, P. L. 1988. Cholesterol and the cell membrane, Pages 121-145, in Yeagle, P. L. (ed.), Biology of Cholesterol, CRC Press, Boca Raton.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fliesler, S.J., Richards, M.J., Miller, Cy. et al. Retinal Structure and Function in an Animal Model that Replicates the Biochemical Hallmarks of Desmosterolosis. Neurochem Res 25, 685–694 (2000). https://doi.org/10.1023/A:1007519321917
Issue Date:
DOI: https://doi.org/10.1023/A:1007519321917